Benzinga··Djs Law GroupNektar Therapeutics Faces Class Action Lawsuit Over Misleading REZOLVE-AA Study Claims
Nektar Therapeutics ($NKTR) faces class action lawsuit alleging false statements about REZOLVE-AA trial protocol adherence, threatening regulatory approval timelines and shareholder value.
NKTRclass action lawsuitfalse statements